U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H29O4S.Na
Molecular Weight 316.432
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM MYRISTYL SULFATE

SMILES

[Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O

InChI

InChIKey=UPUIQOIQVMNQAP-UHFFFAOYSA-M
InChI=1S/C14H30O4S.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17;/h2-14H2,1H3,(H,15,16,17);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula C14H29O4S
Molecular Weight 293.443
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Sodium myristyl sulfate is a surfactant in cosmetic industry and in preparation of toothpastes.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Vallecular varix causing diagnostic confusion in hematemesis.
2008-12
Single dose injection snoreplasty: investigation or treatment?
2008-11
Reverse foam sclerotherapy of the great saphenous vein with sapheno-femoral ligation compared to standard and invagination stripping: a prospective clinical series.
2008-10
Chronic facial pain following injection of sodium tetradecyl sulphate into an intraparotid haemolymphangioma.
2008-09
The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro.
2008-08
Palatal sclerotherapy: a potentially useful treatment of intermittent dorsal displacement of the soft palate in juvenile standardbred racehorses.
2008-06
Subungual pyogenic granuloma treated by sodium tetradecyl sulfate sclerotherapy.
2008-06
Retrograde percutaneous sclerotherapy of left idiopathic varicocele in children: results and follow-up.
2008-05
Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
2008-04
Initial experience with 3% sodium tetradecyl sulfate foam and fibered coils for management of adolescent varicocele.
2008-02
Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate--outcome in 244 patients.
2008-02
The effect of endovenous laser ablation on restless legs syndrome.
2008
[Sclerotherapy of sapheno-femoral reflux of blood in patients with initial stages of varicose disease of the lower extremity veins].
2008
In situ AFM studies on self-assembled monolayers of adsorbed surfactant molecules on well-defined H-terminated Si(111) surfaces in aqueous solutions.
2007-12-18
In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
2007-12
Anaphylactoid reaction after the use of sodium tetradecyl sulfate: a case report.
2007-11-21
Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model.
2007-10-10
Immediate pathologic effects on the vein wall of foam sclerotherapy.
2007-10
The effects of alkyl sulfates on the analysis of phenolic compounds by microchip capillary electrophoresis with pulsed amperometric detection.
2007-10
Percutaneous drainage and ablation of orbital dermoid cysts.
2007-10
Endoscopic abnormalities in the oesophagus after variceal sclerotherapy--a long-term follow up study.
2007-09-28
Photophysics of a cationic biological photosensitizer in anionic micellar environments: combined effect of polarity and rigidity.
2007-09-27
FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy.
2007-09
Comparison of ethanol and sodium tetradecyl sulfate in the sclerotherapy of renal cyst.
2007-08
Use of intraoperative sodium tetradecyl sulfate for the treatment of a spinal epidural hemangioma. Technical note.
2007-08
Foam sclerotherapy with Fibrovein (STD) for the treatment of hemorrhoids, using a flexible endoscope.
2007-08
The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland.
2007-08
Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam.
2007-07-28
Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation.
2007-07
Efficacy of local sclerosing agents on hemostasis of hepatic bleeding.
2007-06
Surfactant chain-length-dependent modulation of the prototropic transformation of a biological photosensitizer: norharmane in anionic micelles.
2007-04-24
Management of oral lesions in HIV-positive patients.
2007-03
Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
2007-03
Profuse bleeding in patients with chronic venous insufficiency.
2007-03
[Injection sclerotherapy for varicosities of the lower limb: 25 years of experience with 115000 injections].
2007-01-14
[The Troyanov-Trendelenburg operation in combination with sclerotherapy as an effective method of outpatient treatment of varicose disease].
2007
[Assessing efficacy of combined use of endovasal laser congulation and echosclerotherapy in comprehensive management of complicated forms of varicose disease].
2007
Anionic hybrid threadlike micelle formation in an aqueous solution.
2006-12-14
Dose- and time-dependent liquid sclerosant effects on endothelial cell death.
2006-12
Threadlike micelle formation of anionic surfactants in aqueous solution.
2006-11-21
Chronic venous disease treated by ultrasound guided foam sclerotherapy.
2006-11
Injection sclerotherapy for varicose veins.
2006-10-18
Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement.
2006-10
Airway rescue with laryngeal mask airway during sclerotherapy of a large arteriovenous malformation in the oral and maxillofacial region.
2006-08
Comparison of the conformational stability of the non-native alpha-helical intermediate of thiol-modified beta-lactoglobulin upon interaction with sodium n-alkyl sulfates at two different pH.
2006-07-15
Classification, diagnosis, and interventional radiologic management of vascular malformations.
2006-07
Management of mandibular vascular malformation with sclerotherapy. Report of two cases.
2006-07
Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.
2006-06
Venous disorders: treatment with sclerosant foam.
2006-02
Thermodynamic characterization of the interaction behavior of a hydrophobically modified polyelectrolyte and oppositely charged surfactants in aqueous solution: effect of surfactant alkyl chain length.
2005-01-13
Patents

Sample Use Guides

in soaps and shampoos
Route of Administration: Topical
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Wed Apr 02 18:29:41 GMT 2025
Edited
by admin
on Wed Apr 02 18:29:41 GMT 2025
Record UNII
2X50FW96YS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM MYRISTYL SULFATE
INCI  
INCI  
Official Name English
NSC-139032
Preferred Name English
1-TETRADECANOL, 1-(HYDROGEN SULPHATE), SODIUM SALT (1:1)
Common Name English
SODIUM N-TETRADECYL SULPHATE
Common Name English
1-TETRADECANOL, HYDROGEN SULPHATE SODIUM SALT
Common Name English
SODIUM MYRISTYL SULPHATE
Systematic Name English
SODIUM N-TETRADECYL SULFATE
Common Name English
1-TETRADECANOL, 1-(HYDROGEN SULFATE), SODIUM SALT (1:1)
Common Name English
1-TETRADECANOL, HYDROGEN SULFATE SODIUM SALT
Common Name English
Code System Code Type Description
NSC
139032
Created by admin on Wed Apr 02 18:29:41 GMT 2025 , Edited by admin on Wed Apr 02 18:29:41 GMT 2025
PRIMARY
ECHA (EC/EINECS)
214-737-2
Created by admin on Wed Apr 02 18:29:41 GMT 2025 , Edited by admin on Wed Apr 02 18:29:41 GMT 2025
PRIMARY
EPA CompTox
DTXSID4042416
Created by admin on Wed Apr 02 18:29:41 GMT 2025 , Edited by admin on Wed Apr 02 18:29:41 GMT 2025
PRIMARY
PUBCHEM
23665770
Created by admin on Wed Apr 02 18:29:41 GMT 2025 , Edited by admin on Wed Apr 02 18:29:41 GMT 2025
PRIMARY
DRUG BANK
DB00464
Created by admin on Wed Apr 02 18:29:41 GMT 2025 , Edited by admin on Wed Apr 02 18:29:41 GMT 2025
PRIMARY
CAS
1191-50-0
Created by admin on Wed Apr 02 18:29:41 GMT 2025 , Edited by admin on Wed Apr 02 18:29:41 GMT 2025
PRIMARY
FDA UNII
2X50FW96YS
Created by admin on Wed Apr 02 18:29:41 GMT 2025 , Edited by admin on Wed Apr 02 18:29:41 GMT 2025
PRIMARY
DRUG CENTRAL
2465
Created by admin on Wed Apr 02 18:29:41 GMT 2025 , Edited by admin on Wed Apr 02 18:29:41 GMT 2025
PRIMARY